<DOC>
	<DOCNO>NCT01805115</DOCNO>
	<brief_summary>The objective study compare efficacy oral , sublingual , vaginal , misoprostol prior operative hysteroscopy premenopausal woman .</brief_summary>
	<brief_title>Misoprostol Administration Before Operative Hysteroscopy</brief_title>
	<detailed_description>The route administration misoprostol cervical dilatation prior operative hysteroscopy oral , vaginal , sublingual . However , still unclear route effective less harmful cervical dilation prior operative hysteroscopy premenopausal woman . Furthermore , study compare among oral , sublingual , vaginal misoprostol , medication ( control ) woman . The objective study compare efficacy safety oral , sublingual , vaginal , misoprostol prior operative hysteroscopy premenopausal woman .</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Symptomatic patient suspect intrauterine pathology , submucosal myoma , endometrial polyp endometrial pathological finding base transvaginal ultrasound , enrol . Inclusion criterion follow : woman reproductive age ( i.e. , premenopausal ) pregnant time presentation ( i.e. , negative urine pregnancy test last menstrual period within last 4 week ) . Exclusion criterion include evidence contraindication prostaglandin ( history severe asthma , glaucoma , preexist severe cardiac disease , renal failure ) , allergy prostaglandin , sign genital infection , presence significant uterovaginal prolapse could affect administration vaginal tablet , history cervical surgery , presence space occupy lesion endocervical canal , treatment GnRH agonist .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>hysteroscopy</keyword>
	<keyword>misoprostol</keyword>
</DOC>